Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. [electronic resource]
- Annals of clinical microbiology and antimicrobials Mar 2018
- 13 p. digital
Publication Type: Journal Article
1476-0711
10.1186/s12941-018-0267-8 doi
Adult Aged Aged, 80 and over Anti-Bacterial Agents--therapeutic use Bacteremia--drug therapy Biliary Tract Diseases--drug therapy Body Fluids--microbiology Carbapenem-Resistant Enterobacteriaceae--drug effects China Cross Infection--drug therapy Drug Resistance, Multiple, Bacterial--drug effects Enterobacter cloacae--pathogenicity Enterobacteriaceae--drug effects Enterobacteriaceae Infections--drug therapy Escherichia coli--drug effects Female Hospitalization Hospitals Humans Intensive Care Units Klebsiella oxytoca--drug effects Klebsiella pneumoniae--pathogenicity Male Middle Aged Pneumonia--drug therapy Pneumonia, Ventilator-Associated--drug therapy Prevalence Pyelonephritis--drug therapy Retrospective Studies Risk Factors Sepsis--drug therapy Tertiary Care Centers Treatment Outcome Urinary Tract Infections--drug therapy Wound Infection--drug therapy Young Adult